Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
RPGLIFE.NS
BuyPremium GrowerRPG Life Sciences Limited · Healthcare · India · $489M · Avg Vol: $505K/d
79
StockRankGet insider-trade alerts
Q
73
V
25
M
76
P/E (TTM)
38.9x
ROE
19.0%
D/E
0.0x
Dividend %
0.9%
COMPANY DESCRIPTION
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
FINANCIAL SUMMARY (INR)
| Year | 2022 | 2023 | 2024 | 2025 | 2026 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 5.1B | 5.8B | 6.5B | 7.0B | 11.3% | 7.3B | 8.6B | 10.0B | 19.6% |
| EPS (INR) | — | 40.90 | 53.01 | 110.80 | 69.64 | 19.4% | 72.31 | 77.10 | 94.20 | 16.3% |
| Shares | — | 16.5M | 16.5M | 16.5M | 16.5M | 0.0% | 16.5M | — | — | — |
| Debt | 9.4M | 0.1M | 0 | — | 200.0M | 114.8% | 200.0M | — | — | — |
| Equity | — | 3.1B | 3.7B | 5.3B | 6.1B | 25.3% | — | — | — | — |
| Op CF | — | 908.2M | 943.6M | 778.6M | 565.0M | -14.6% | 565.0M | — | — | — |
| Inv CF | — | -1.1B | -791.5M | -418.0M | 858.4M | — | — | — | — | — |
| Fin CF | — | -171.2M | -203.1M | -270.8M | -205.8M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)-1.3%
SMA 50SMA 200
Close
$29.57
RSI (14)
63.1
52W High
$32.41
From 52W High
0.9%
SCORE BREAKDOWN
Quality
73
ROIC
24.5%94.0
ROE
19.0%87.4
GP/Assets
59.1%90.8
Op. Margin
19.1%81.7
FCF/Assets
-1.1%42.4
Piotroski
321.9
Int. Cover
50.0x89.2
D/E Ratio
0.03x75.3
Current Ratio
3.48x61.2
Value
25
P/E (TTM)
38.9x29.1
EV/EBITDA
28.5x22.6
P/FCF
—N/A
P/B
7.7x16.6
P/S
6.3x35.9
Div Yield
0.9%24.9
Momentum
76
52W High %
91%86.7
RS 6M
53%91.6
SMA 50/200
1.20x87.6
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+30%42.3
Q Growth
17%52.8
FUNDAMENTALS
Market Cap
$489M
P/E (Forward)
29.9x
Gross Margin
63.8%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of RPGLIFE.NS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| RPGLIFE.NS | RPG Life Sciences Limited(you) | $489M | 79 | Buy |
| AARTIDRUGS.NS | Aarti Drugs Limited | $406M | 80 | Strong Buy |
| FDC.NS | FDC Limited | $594M | 76 | Buy |
| INNOVACAP.NS | Innova Captab Limited | $707M | 79 | Buy |
| GUFICBIO.NS | Gufic Biosciences Limited | $466M | 71 | Buy |
| SOLARA.NS | Solara Active Pharma Sciences Limited | $357M | 81 | Strong Buy |
| INDSWFTLAB.NS | Ind-Swift Laboratories Limited | $356M | 81 | Strong Buy |
| HIKAL.NS | Hikal Limited | $320M | 75 | Buy |
| UNICHEMLAB.NS | Unichem Laboratories Limited | $413M | 87 | Strong Buy |
| SAKAR.NS | Sakar Healthcare Limited | $268M | 79 | Buy |
Peer medians: ROE 11.8% · P/E 42.8x · Gross margin 59.4%